Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV

AIDS. 2023 Jul 1;37(8):1341-1342. doi: 10.1097/QAD.0000000000003564.

Authors

Rui Jiang¹, Jianjun Sun, Bihe Zhao, Renfang Zhang, Li Liu, Jun Chen

Affiliation

¹ Department of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
HIV Infections* / complications
HIV Infections* / drug therapy
Humans

Substances

azvudine